Labcorp EBIT 2010-2025 | LH

Labcorp EBIT for the quarter ending March 31, 2025 was $0.326B, a 1.46% increase year-over-year.

  • Labcorp 2024 EBIT was 1.087B, a 49.77% increase from 2023.
  • Labcorp 2023 EBIT was 0.726B, a 49.49% decline from 2022.
  • Labcorp 2022 EBIT was 1.437B, a 52.88% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

Labcorp EBIT 2010-2025 | LH

  • Labcorp 2024 EBIT was 1.087B, a 49.77% increase from 2023.
  • Labcorp 2023 EBIT was 0.726B, a 49.49% decline from 2022.
  • Labcorp 2022 EBIT was 1.437B, a 52.88% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$87.4B
Becton Dickinson (BDX)$57.1B
Cardinal Health (CAH)$32.5B
Straumann Holding AG (SAUHY)$18.7B
Cooper (COO)$15.9B
West Pharmaceutical Services (WST)$14.6B
Align Technology (ALGN)$12.5B
Henry Schein (HSIC)$7.9B
Merit Medical Systems (MMSI)$5.4B
Patterson (PDCO)$2.8B
DENTSPLY SIRONA (XRAY)$2.6B
CONMED (CNMD)$1.5B
STAAR Surgical (STAA)$833M
Pro-Dex (PDEX)$198M
Lifevantage (LFVN)$169M